ROTH Capital Partners

ROTH Capital Partners is an investment banking firm established in 1984 and headquartered in Newport Beach, California. The firm specializes in the small-cap public market, offering a range of services including capital raising, research coverage, trading, market-making, mergers and acquisitions, and initial public offerings. ROTH has a history of innovation in this sector, having participated in underwriting IPOs for small-cap companies in the 1990s and developing the PIPE (private investment in public equity) financing structure as market dynamics evolved. The firm was also a pioneer in financing small-cap Chinese companies, establishing a Representative Office in Shanghai in 2007 and a Limited Office in Hong Kong in 2010. Its expertise spans various sectors, including consumer, healthcare, industrial growth, clean technology, resources, technology, and media.

Charles Campbell

Managing Director, Trading Desk Specialist

Eric Cheng

Managing Director, Head of Healthcare Investment Banking

Jason Wittes

Managing Director, Senior Research Analyst

Jonathan Aschoff Ph.D

Managing Director and Senior Analyst, Research

41 past transactions

Moleculin

Post in 2025
Moleculin Biotech is a clinical-stage pharmaceutical company focused on the development of oncology drug candidates, some of which are based on discoveries made at M.D. Anderson Cancer Center. Their clinical stage drugs are Annamycin, an anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity being studied for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as AML, and WP1066, an immuno-stimulating STAT3 inhibitor targeting brain tumors, pancreatic cancer, and AML. They are also engaged in the preclinical development of additional drug candidates, including additional STAT3 inhibitors and compounds targeting the metabolism of tumors.

Moleculin

Post in 2025
Moleculin Biotech is a clinical-stage pharmaceutical company focused on the development of oncology drug candidates, some of which are based on discoveries made at M.D. Anderson Cancer Center. Their clinical stage drugs are Annamycin, an anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity being studied for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as AML, and WP1066, an immuno-stimulating STAT3 inhibitor targeting brain tumors, pancreatic cancer, and AML. They are also engaged in the preclinical development of additional drug candidates, including additional STAT3 inhibitors and compounds targeting the metabolism of tumors.

Kept

Seed Round in 2023
Kept specializes in compassionate offboarding services for employees transitioning between jobs. The company provides a comprehensive suite of support that includes compliance assistance, health insurance options, and financial resources. By focusing on the needs of departing employees, Kept ensures that clients can navigate post-employment benefits effectively, facilitating a smoother transition during career changes.

Akoustis Technologies

Post in 2023
Akoustis Technologies, Inc. is a high-tech semiconductor company based in Huntersville, North Carolina, that specializes in the development, design, manufacturing, and sale of radio frequency (RF) filter products for the mobile wireless device industry. Established in 2013, the company operates through two main segments: Foundry Fabrication Services and RF Filters. The Foundry Fabrication Services segment offers engineering review and semiconductor wafer-manufacturing services, while the RF Filters segment focuses on producing innovative amplifier and filter products for various applications, including smartphones, tablets, cellular infrastructure, Wi-Fi equipment, and military uses. Akoustis utilizes a proprietary microelectromechanical systems-based technology known as XBAW to create its filters, enabling efficient production and unique performance characteristics. The company generates revenue primarily through individual customer purchase orders.

New Found Gold

Post in 2022
New Found Gold Corp. is a mineral exploration company based in Vancouver, Canada, that focuses on the identification, acquisition, and exploration of gold properties in Newfoundland and Labrador and Ontario. The company is primarily engaged in exploring for gold deposits and holds a significant interest in the Queensway project, which encompasses 86 mineral licenses and 6,041 claims across an area of 151,030 hectares near Gander, Newfoundland. Founded in 2016, New Found Gold aims to discover and delineate gold resources within its extensive land holdings.

UNION

Series B in 2021
UNION POS specializes in developing UNION TAB, a customizable iPad-based point of sale software tailored for bars and restaurants. Established in 2009 and headquartered in Austin, Texas, UNION POS focuses on meeting the unique needs of high-volume, high-touch venues. Their system offers a fast and intuitive interface that simplifies reporting and operational processes, allowing users to dedicate more time to customer engagement. The software includes features such as inventory management and loyalty programs, all supported by 24/7 live assistance and competitive processing fees. UNION POS aims to create a seamless experience that enhances operational efficiency while enabling businesses to concentrate on delivering exceptional service.

Riley Permian

Venture Round in 2021
Riley Permian specializes in the exploration and production of oil and natural gas, with a primary focus on high-growth opportunities in the Permian Basin. The company emphasizes the horizontal development of the San Andres Formation, leveraging its technical expertise and advanced evaluation techniques. In addition to its core operations in the Permian Basin, Riley Permian also manages properties in Kansas and Tennessee. The company is recognized for its operational experience, which positions it as a leader in acquiring, developing, and producing energy resources.

FalconStor Software

Post in 2021
FalconStor Software, Inc. is a storage software company that specializes in data migration, business continuity, disaster recovery, optimized backup, and de-duplication solutions. Founded in 1994 and headquartered in Austin, Texas, FalconStor develops a range of products, including its virtual tape library, which emulates traditional tape libraries for data preservation without requiring changes to existing backup systems. The company also offers solutions such as FalconStor storsafe for long-term archive management, FalconStor continuous data protector for instant data recovery, and FalconStor network storage server for data virtualization in diverse environments. FalconStor's innovative technology is backed by over 30 patents and is utilized by more than 1,000 enterprise customers, along with a network of managed service providers and resellers globally. The company's products are distributed through various channels, including authorized partners, system integrators, and direct sales to customers.

Cambium Networks

Post in 2021
Cambium Networks Corporation is a provider of wireless broadband networking infrastructure solutions tailored for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. Founded in 2011 and headquartered in Rolling Meadows, Illinois, the company offers a comprehensive wireless fabric that includes intelligent radios, smart antennas, and network management software. Cambium's product portfolio features point-to-point solutions connected to high-speed wireline networks and wireless broadband backhaul, enabling robust connectivity over distances of up to 100 kilometers at speeds of 2 gigabits per second. Their cnPilot and Xirrus Wi-Fi solutions cater to both indoor and outdoor environments, while cnReach offers narrow-band connectivity for sensors and devices. Additionally, the cnMatrix cloud-managed switching solution integrates wireless and wired networks seamlessly. Cambium Networks operates across various regions, including North America, Europe, the Middle East, Africa, Central and Latin America, and the Asia-Pacific, with the majority of its revenue generated in North America.

Celsius Holdings

Post in 2021
Celsius Holdings, Inc. is a company that develops, markets, and distributes functional calorie-burning fitness beverages, catering to health-conscious consumers in the United States and internationally. Founded in 2004 and based in Boca Raton, Florida, Celsius offers a diverse range of beverages, including carbonated and non-carbonated options in various flavors, as well as dietary supplements such as Celsius Heat. The company emphasizes natural ingredients and metabolism-enhancing formulations, appealing to fitness enthusiasts and individuals pursuing an active lifestyle. Celsius products are distributed through a variety of channels, including direct-store delivery, supermarkets, convenience stores, drug stores, nutritional shops, health clubs, and e-commerce platforms. Formerly known as Vector Ventures, Inc., the company rebranded to Celsius Holdings, Inc. in January 2007, reflecting its focus on energy drinks within the global nonalcoholic beverage market.

Reed's

Post in 2021
Reed's is a manufacturer of naturally brewed sodas, specializing in handcrafted, all-natural beverages made using traditional methods and fresh ingredients. The company offers a diverse portfolio that includes its flagship Ginger Beer brand and Virgil's Handcrafted sodas. Reed's products are widely available, sold in over 45,000 retail outlets across the United States. These include natural and specialty food channels, grocery stores, mass merchants, drug stores, convenience stores, club stores, and various on-premise locations such as bars and restaurants. Reed's commitment to quality and natural ingredients sets it apart in the beverage market.

Adomani

Post in 2021
Adomani specializes in providing zero-emission electric and hybrid vehicles, along with integrated drivetrain solutions for a variety of sectors, including commercial fleets, school districts, and transportation services. The company addresses the challenges associated with traditional fuel price volatility and regulatory compliance by offering cost-effective alternatives that promote environmental sustainability. Adomani's product offerings include electric and hybrid drivetrain systems designed for new vehicles, as well as patented conversion kits that retrofit existing combustion-powered vehicles. Their focus on innovative solutions positions them as a key player in the transition to cleaner transportation options for both public and private entities.

DMC Global

Funding Round in 2021
DMC Global is an industrial manufacturer specializing in niche markets that support the infrastructure of the process and energy industries. The company operates through three segments: NobelClad, DynaEnergetics, and Arcadia Products. NobelClad focuses on producing explosion-welded clad metal plates, which are utilized in constructing corrosion-resistant industrial processing equipment. DynaEnergetics designs and manufactures products for the global oil and gas industries, while Arcadia Products supplies architectural building materials, including framing systems and storefronts, primarily for the commercial construction market. DMC Global has operations in the United States, Germany, and France, demonstrating its international presence in specialized manufacturing. The company expanded its capabilities in 2012 with the acquisition of TRX Industries, enhancing its offerings in the technical products and process sectors.

Ocugen

Post in 2021
Ocugen, Inc. is a clinical-stage biopharmaceutical company based in Malvern, Pennsylvania, dedicated to discovering, developing, and commercializing innovative therapies aimed at curing blinding diseases. The company's pipeline includes several promising product candidates, such as OCU200, a novel fusion protein in preclinical development for treating wet age-related macular degeneration (AMD), diabetic retinopathy, and diabetic macular edema. Additionally, Ocugen is developing OCU400 for retinitis pigmentosa, a rare genetic disorder, and OCU410 for dry AMD. The company utilizes its Modifier Gene Therapy Platform to address unmet medical needs in the field of retinal diseases, including inherited conditions and multifactorial diseases. Ocugen has also established a strategic partnership with CanSino Biologics Inc. for the co-development and manufacturing of gene therapies.

Bally Technologies

Private Equity Round in 2021
Bally Technologies, Inc. is a global gaming company that specializes in the design, manufacture, distribution, and operation of gaming devices and technology. The company provides a variety of electronic gaming machines, table game products, and computerized systems for monitoring, accounting, and player tracking. Bally Technologies supports gaming operators by offering diverse purchase and lease options, as well as services aimed at enhancing operational efficiency and revenue generation. The company's revenue streams are primarily derived from the sale of gaming equipment, including devices and related components, and from gaming operations, which encompass the management of linked progressive systems, video lottery systems, and the rental of gaming content and devices.

GIGA TRONICS

Post in 2021
Giga-tronics is a prominent manufacturer specializing in engineering and designing top-quality RF and microwave test equipment such as signal generators, power amplifiers, power meters, signal switching units, and other components. Their products cater to R&D, production, and test professionals in various industries including aerospace & defense, communications, and microwave component testing. Giga-tronics' equipment is widely used globally to enhance productivity and simplify operations in applications such as ATE systems.

VIRTRA SYSTEMS

Post in 2021
VirTra, Inc. specializes in the development and sale of judgmental use of force and firearms training simulators for law enforcement, military, and civilian applications worldwide. The company offers a range of products, including the V-300 simulator, featuring a 300-degree wrap-around screen, the V-180 simulator for smaller spaces, and the V-100 and V-ST simulators for various training needs. Additionally, VirTra provides the V-Author software, which enables users to create and customize training content, along with simulated recoil kits and the Threat-Fire device that enhances training by introducing real-world stressors. The company also offers the VirTra Driving Sim, a vehicle-based simulator, and various training programs, including a subscription service for accessing its simulators and coursework. VirTra's products are marketed through a direct sales force and international distribution partners, with a commitment to providing installation, training, and ongoing support for its systems. Founded in 1993 and headquartered in Tempe, Arizona, VirTra has established itself as a key player in the training simulation industry.

VBL Therapeutics

Post in 2021
VBL Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for cancer and immune-inflammatory diseases. The company’s clinical pipeline features two proprietary platform technologies that utilize the body’s natural biological and genetic mechanisms. Their lead product candidate, VB-111, is a gene-based biologic aimed at treating solid tumors, particularly recurrent glioblastoma, an aggressive brain cancer. In addition to its oncology efforts, VBL is also working on therapies for anti-inflammatory conditions through its Lecinoxoid platform technology. The company is dedicated to advancing first-in-class treatments that address significant unmet medical needs.

Array Technologies

Post in 2021
Array Technologies, Inc. specializes in solar tracking solutions and services tailored for utility-scale projects. Founded in 1989 and headquartered in Albuquerque, New Mexico, the company has established itself as a pioneer in the solar tracking industry, offering innovative and cost-effective products such as the DuraTrack HZ v3, a single-axis solar tracking system, and SmarTrack, a machine learning software that optimizes module angles based on weather and site conditions. With over 20 years of experience, Array Technologies manufactures its trackers in the United States and distributes them globally, serving a diverse clientele that includes utilities, corporations, small businesses, and homeowners. The company has successfully deployed tracker installations in various international markets, including Spain, Italy, China, Korea, and the United States.

Thomson Resources

Post in 2021
Thomson Resources Ltd is an Australian mining exploration company specializing in the discovery and development of base and precious metal deposits. Established in 2009 and based in St Leonards, the company primarily targets gold, silver, tin, copper, lead, and zinc resources. Thomson Resources conducts exploration activities across several projects, including the Bygoo project in Ardlethan, the Harry Smith Gold project, and the Chillagoe Gold project in North Queensland. The company is actively engaged in assessing and acquiring mineral properties, with a keen focus on the New England Fold Belt of Northern New South Wales, where it aims to identify significant mineral deposits with substantial potential.

Sunworks USA

Private Equity Round in 2021
Sunworks, Inc. (NASDAQ: SUNW) is a premier provider of high performance solar power systems. They are committed to quality business practices that exceed industry standards and uphold their ideals of ethics and safety. Sunworks continues to grow its presence, expanding nationally with regional and local offices. They strive to consistently deliver high quality, performance oriented solutions for customers in a wide range of industries including agricultural, commercial and industrial, federal, public works, and residential. Their dedication to excellence is reflected in commitment to support our customers above and beyond their expectations. Sunworks’ diverse, seasoned workforce includes distinguished veterans who bring a sense of pride, discipline, and professionalism to their interaction with customers. All of their employees uphold our company’s guiding principles each day. Sunworks is a member of the Solar Energy Industries Association (SEIA) and is a proud advocate for the advancement of solar power.

McEwen Mining

Post in 2020
McEwen Mining Inc. is a mining and minerals production company focused on the exploration, development, production, and sale of gold and silver, primarily in the Americas. The company operates wholly-owned mines such as the El Gallo 1 mine in Mexico and holds a 49% interest in the San José silver-gold mine in Argentina. It also owns various exploration and development projects, including the Gold Bar project in Nevada and the Los Azules copper deposit in Argentina. McEwen Mining's other properties include the Black Fox Mine and multiple exploration sites in Canada. Founded in 1979 and headquartered in Toronto, Canada, the company aims to be a profitable mid-tier producer of precious metals. With a significant focus on gold and silver, McEwen Mining's operations are geographically diverse, with substantial output derived from its projects in Canada and Mexico.

Lumitron Technologies

Venture Round in 2020
Lumitron Technologies specializes in the development and commercialization of advanced X-ray and laser technology aimed at enhancing imaging and therapeutic practices in healthcare. The company utilizes a novel high-energy laser light source, known as Laser-Compton, to replicate the capabilities of large-scale synchrotrons in a compact form comparable to a modern CT scanner, significantly reducing costs. Lumitron's innovative systems enable ultra-high-fidelity imaging, ultra-low dose radiography, and hyper-precision radiotherapy, allowing for the identification of medical issues, such as tumors, with greater detail and accuracy. Additionally, the technology facilitates element-specific and isotope-specific material identification, enabling healthcare providers to perform targeted imaging and therapy simultaneously, all within existing clinical treatment environments.

Intec Pharma

Post in 2018
Intec Pharma Ltd is a clinical-stage biopharmaceutical company based in Jerusalem, Israel, dedicated to developing drugs using its proprietary Accordion Pill platform technology. This innovative oral drug delivery system aims to enhance the efficacy and safety of both existing and new medications through a specialized gastric retention and release mechanism. The company's lead candidate, Accordion Pill Carbidopa/Levodopa, is undergoing Phase III clinical trials for treating symptoms of advanced Parkinson's disease. Additionally, Intec Pharma is developing Accordion Pill Zaleplon, also in Phase III trials, for insomnia management, and has other candidates aimed at preventing and treating NSAID-induced ulcers, as well as products containing Cannabidiol and Tetrahydrocannabinol for various pain conditions. The company has established collaborations, including a research agreement with Merck to explore the Accordion Pill platform and a feasibility agreement with GW Research Limited for an undisclosed research initiative. Founded in 2000, Intec Pharma was previously known as Intec Pharmaceuticals before rebranding in 2004.

Gazillion

Series C in 2017
Gazillion Entertainment is a gaming company headquartered in Foster City, California, specializing in the development and publication of multiplayer online games. The company focuses on creating immersive gaming experiences that feature both well-known brands and original franchises. With an emphasis on high production quality and engaging gameplay, Gazillion has established a reputation for building online game worlds inspired by comic book characters, fostering a vibrant community for players. Through its diverse offerings, Gazillion aims to deliver innovative and entertaining gaming experiences across multiple platforms.

Biocept

Post in 2017
Biocept, Inc. is a molecular oncology diagnostics company that develops and commercializes innovative assays for circulating tumor cells and circulating tumor DNA, utilizing standard blood samples. Its cancer assays provide critical information for healthcare providers to identify oncogenic alterations in diverse solid tumors, including breast, lung, gastric, colorectal, prostate, melanoma, pancreaticobiliary, and ovarian cancers. The company employs its patented Target-Selector technology to enhance the sensitivity and specificity of mutation detection. Biocept also offers laboratory services to various medical professionals, aiding in the development of treatment plans for cancer patients. In addition to its blood-based liquid biopsy assays, Biocept has created the CNSide cerebrospinal fluid assay to detect metastasized cancer in the central nervous system. The company's clinical laboratory is accredited and operates under strict regulatory standards. Biocept markets its diagnostic assays directly to healthcare providers and collaborates with pharmaceutical companies and clinical research organizations for drug development and research services. Founded in 1997, Biocept is headquartered in San Diego, California.

Gazillion

Series B in 2016
Gazillion Entertainment is a gaming company headquartered in Foster City, California, specializing in the development and publication of multiplayer online games. The company focuses on creating immersive gaming experiences that feature both well-known brands and original franchises. With an emphasis on high production quality and engaging gameplay, Gazillion has established a reputation for building online game worlds inspired by comic book characters, fostering a vibrant community for players. Through its diverse offerings, Gazillion aims to deliver innovative and entertaining gaming experiences across multiple platforms.

Smule

Series G in 2016
Smule, Inc. is a San Francisco-based company that specializes in developing music applications aimed at connecting users through collaborative music creation. Founded in 2008, Smule's platform allows individuals to sing and produce music together, fostering a global community of music enthusiasts. Its popular products include AutoRap, Magic Piano, Guitar!, I Am T-Pain, and Ocarina, which enable users to create, discover, and enjoy music in innovative ways. By combining social interaction with music-making, Smule has established itself as a leader in the music app industry, facilitating connections between users and major artists worldwide.

SunBasket

Series A in 2016
Sun Basket is a meal kit subscription service that delivers organic ingredients and customized recipes directly to customers' homes. The company offers a variety of meal options, including Paleo, Gluten-Free, and Vegetarian, allowing customers to select meals each week or follow a specific menu plan. By sourcing organic and sustainable ingredients from over 135 farms, ranches, and fishermen, Sun Basket ensures the use of non-GMO produce and antibiotic and hormone-free meats, while adhering to sustainability standards set by the Monterey Bay Aquarium. This service not only simplifies meal planning and grocery shopping but also encourages a healthier cooking experience, enabling customers to focus on preparing and enjoying their meals.

Gazillion

Series A in 2016
Gazillion Entertainment is a gaming company headquartered in Foster City, California, specializing in the development and publication of multiplayer online games. The company focuses on creating immersive gaming experiences that feature both well-known brands and original franchises. With an emphasis on high production quality and engaging gameplay, Gazillion has established a reputation for building online game worlds inspired by comic book characters, fostering a vibrant community for players. Through its diverse offerings, Gazillion aims to deliver innovative and entertaining gaming experiences across multiple platforms.

SunBasket

Venture Round in 2015
Sun Basket is a meal kit subscription service that delivers organic ingredients and customized recipes directly to customers' homes. The company offers a variety of meal options, including Paleo, Gluten-Free, and Vegetarian, allowing customers to select meals each week or follow a specific menu plan. By sourcing organic and sustainable ingredients from over 135 farms, ranches, and fishermen, Sun Basket ensures the use of non-GMO produce and antibiotic and hormone-free meats, while adhering to sustainability standards set by the Monterey Bay Aquarium. This service not only simplifies meal planning and grocery shopping but also encourages a healthier cooking experience, enabling customers to focus on preparing and enjoying their meals.

Revel Systems

Series C in 2015
Revel Systems, Inc. is a manufacturer and distributor of cloud-based point of sale (POS) and business management solutions. Founded in 2010 and headquartered in Atlanta, Georgia, with additional offices in locations such as San Francisco, Lithuania, Singapore, Australia, and London, the company provides a comprehensive platform that integrates POS software with essential management tools. Its offerings include Revel Essential for small chains and merchants, and Revel Enterprise, designed for larger chains and global enterprises. The platform features capabilities such as inventory management, employee management, integrated payroll, and customer relationship management, all accessible through iOS-based technology on iPads. Revel Systems serves a diverse range of industries, including restaurants, retail, grocery, and service sectors, enabling clients to enhance their operations, improve customer experience, and streamline business processes.

RedHill Biopharma

Post in 2015
RedHill Biopharma Ltd. is a specialty biopharmaceutical company headquartered in Tel Aviv, Israel, with a primary focus on gastrointestinal and infectious diseases. The company develops and promotes several gastrointestinal drugs, including Movantik for opioid-induced constipation, Talicia for treating Helicobacter pylori infection, and Aemcolo for travelers' diarrhea. RedHill's late-stage clinical development programs include RHB-204, aimed at treating pulmonary nontuberculous mycobacteria infections; RHB-104 for Crohn's disease; and RHB-102 (Bekinda), which has shown promise in Phase 3 studies for acute gastroenteritis and gastritis. Additionally, the company is advancing RHB-107, a serine protease inhibitor for cancer and inflammatory gastrointestinal diseases, and opaganib, which is being investigated for various conditions, including COVID-19. Founded in 2009, RedHill Biopharma is committed to innovation in the management of gastrointestinal and infectious diseases.

LiquidSpace

Series C in 2014
LiquidSpace, Inc. is a company that operates a mobile and web application designed to connect individuals seeking workspace with venues that offer available office space. Founded in 2010 and based in Palo Alto, California, LiquidSpace facilitates short-term office rentals and enables desk-seeking employees to find unused workspaces. The platform simplifies the commercial real estate process by allowing users to discover, transact, and manage office space on flexible terms. It provides options for on-demand workspaces by the hour or day, as well as longer-term rentals, including dedicated workspaces and private office suites. By offering access to a wide range of coworking space brands, LiquidSpace supports enterprises in managing their workspace needs, tracking usage, and controlling budgets through a centralized platform.

Rant

Venture Round in 2014
Rant, Inc. is an innovative online media company founded in 2010 by Brett Rosin and Grant Brown in Winfield, Illinois. Initially established with RantSports, a comprehensive hub for sports team blogs, the company has since expanded its portfolio to include RantLifestyle and RantChic, targeting lifestyle, fitness, entertainment, and celebrity topics. The company transitioned its headquarters through several locations, culminating in an office in Irvine, California, where it operates with a team of 24 full-time employees and a diverse writing staff. Rant, Inc. focuses on publishing original digital content across various subjects, allowing users to engage and share their thoughts and experiences. This strategic expansion reflects the company’s commitment to enhancing media consumption and broadening its audience reach.

Smule

Series E in 2014
Smule, Inc. is a San Francisco-based company that specializes in developing music applications aimed at connecting users through collaborative music creation. Founded in 2008, Smule's platform allows individuals to sing and produce music together, fostering a global community of music enthusiasts. Its popular products include AutoRap, Magic Piano, Guitar!, I Am T-Pain, and Ocarina, which enable users to create, discover, and enjoy music in innovative ways. By combining social interaction with music-making, Smule has established itself as a leader in the music app industry, facilitating connections between users and major artists worldwide.

AmpliPhi Biosciences

Post in 2013
AmpliPhi Biosciences is a biopharmaceutical company that specializes in developing bacteriophage-based therapies for bacterial infections. By utilizing naturally occurring viruses known as bacteriophages, the company aims to address various bacterial infections, particularly those caused by drug-resistant strains prevalent in hospital environments. AmpliPhi has established a drug development and manufacturing platform that enables the rapid creation and production of multiple phage-based therapies. The company’s initial focus is on treating acute and chronic infections affecting the lungs, sinuses, and gastrointestinal tract. With operations in Richmond, Virginia, Colworth Science Park near London, and outside Sydney, Australia, AmpliPhi is committed to advancing its pipeline of phage therapies to effectively combat targeted bacterial diseases.

SOASTA

Series E in 2013
SOASTA, Inc. is a performance analytics platform that specializes in cloud testing and monitoring solutions for web and mobile applications. Founded in 2006 and headquartered in Mountain View, California, the company provides comprehensive tools that help digital businesses analyze and optimize their performance in real-time. Its offerings include mPulse, a real user monitoring solution that correlates performance with business outcomes; CloudTest, a platform for load and performance testing; TouchTest, which focuses on mobile functional test automation; and the Digital Operations Center, which delivers insights into performance metrics. SOASTA has conducted over 10 million tests and measured more than 100 billion user experiences, serving a range of industry-leading clients. The company also offers a variety of support services, including testing consultation, training, and development assistance, ensuring that clients can effectively manage their digital performance strategies. As of 2017, SOASTA operates as a subsidiary of Akamai Technologies.

Celator Pharmaceuticals

Private Equity Round in 2013
Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company specializes in creating optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Celator's product pipeline includes VYXEOS, a liposomal formulation of irinotecan and floxuridine, currently undergoing Phase III clinical trials for acute myeloid leukemia (AML). Additionally, CPX-351, another liposomal formulation of cytarabine and daunorubicin, is also in Phase III studies for AML. CPX-1, a combination of irinotecan and floxuridine, has completed Phase II trials targeting colorectal cancer. The company also has a preclinical candidate, CPX-8, which is a nanoparticle formulation of docetaxel. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

Natus Medical

Venture Round in 2006
Natus Medical is a prominent provider of healthcare products focused on the screening, diagnosis, treatment, and monitoring of various medical conditions. The company specializes in products for newborn care, hearing impairments, neurological dysfunctions, epilepsy, sleep disorders, and balance and mobility disorders. Natus offers a range of non-invasive medical instruments and disposables, including computerized neurodiagnostic systems for audiology and neurology, as well as newborn care devices such as hearing screening systems, phototherapy equipment for jaundice, head-cooling products for brain injury treatment, and incubators to create optimal environments for newborns. Additionally, Natus provides software solutions for managing and tracking disorders, serving public health laboratories and enhancing the accuracy of patient diagnoses in healthcare settings.

Infinilink

Series A in 2000
Infinilink s an early-stage technology company specializing in OEM products for delivering high speed digital communications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.